USD/CAD is holding above its 100-day moving average at 1.4247, BBH's FX analysts report.
High inflation and negative growth prospect are a drag for CAD
"Canada inflation ran hot in February. Headline inflation rose to 2.6%y/y (consensus: 2.2%) vs. 1.9% in January. Core inflation (average of trim and median CPI) quickened to 2.9% y/y (consensus: 2.75%) vs. 2.7% in January. Sales taxes were reapplied to eligible products mid-February which put upward pressure on consumer prices as taxes paid by consumers are included in the CPI."
"Headline and core CPI inflation are tracking above the Bank of Canada’s (BOC) Q1 projection of 2.1% and 2.5%, respectively. The implication is the BOC has limited room to ease policy further to offset the drag to growth from heightened trade policy uncertainty. The combination of high inflation and unfavorable growth prospect is a drag for CAD."
Related Articles
Costco FY2025 Q4 Earnings Preview: Decoding Growth Drivers and Market Bets Amid Sky-High Valuation
TradingKey - Since the release of Costco's fiscal 2025 third-quarter earnings report, its stock performance has slightly underperformed the S&P 500 index. After a significant year-to-date rally, the stock has entered a consolidation phase, exhibiting a contracting triangle pattern, reflecting...
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilize
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks ahead
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.
